Expert technical analysis of financial markets by JC Parets
by David
As the sleepy summer season carries on, so do the short Hot Lists.
Director Timothy J. Wilmott revealed an acquisition worth $1.2 million in Darden Restaurants $DRI.
Mario Gabelli’s GAMCO Investors filed a 13D revealing an ownership stake of 22.3% in Telesat Corporation $TSAT.
by David
It’s another brief Hot List today.
Neil Gagnon, the CEO of Gagnon Advisors LLC, revealed a purchase of approximately 43,200 shares in the small-cap software company SecureWorks Corp $SCWX.
by David
Today’s Hot List is a short one.
Patrick S. Barrett, executive vice-president and CFO of OceanFirst Financial Corp $OCFC, revealed a purchase of approximately 10,500 shares in his own stock.
by David
The largest insider buy on today’s list is yet another Form 4 filing by Warren Buffett’s Berkshire Hathaway $BRK.A.
Buffett just revealed an additional purchase in Occidental Petroleum $OXY, as he continues to build his position in the energy stock.
by David
The largest insider transaction on today’s list is a Form 4 filing by Nimish P. Shah, who reported a purchase of roughly $5.1 million of Tricida $TCDA.
Thomas Meth, the president of Enviva $EVA, reported a purchase of 8,600 shares, equivalent to $505,508 worth of stock.
by David
The largest insider buy on today’s list is a Form 4 filing by Turtle Creek Asset Management, which revealed a 496,000-share purchase of JELD-WEN Holding $JELD.
In his latest Form 4, the chairman and CEO of Enviva $EVA revealed a purchase of approximately $1 million in the lumber and wood company.
by David
The largest insider buy on today’s list is a Form 4 filing by Michael Gladstone, independent director at Day One Biopharmaceuticals $DAWN.
Gladstone disclosed the purchase of approximately $11.5 million worth of shares in the mid-cap biotech company.
by David
SkyKnight Capital Fund disclosed the purchase of approximately $1.6 million worth of shares in the home medical equipment company AdaptHealth Corp $AHCO, as it continues to build a position in the stock.
The fund now owns 8,906,070 shares, which represents a roughly 6.15% ownership stake in the medical devices company.
